Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

0

0

Frost & Sullivan’s recent analysis, Technological Advances Facilitating Research across Preclinical Disease Models, finds that the cross-synergy among five disciplines—artificial intelligence-powered systems, gene editing, quantum computing, 3D bioprinting, and bioelectronics—is driving the adoption of highly accurate, efficient, and specific preclinical disease models for a wide variety of therapeutic areas. The adoption of these technologies in preclinical research is saving time and expenditure while delivering precise, reliable information.

This article was first featured at https://news.yahoo.com/frost-sullivan-reveals-technological-advances-175500488.html on July 13, 2020 at 02:09PM by

John Jason Fallows

See author's posts